CXCL8 and Hypertension: Various as‐yet unproven suggestions have been made that high or increasing levels of IL‐8 during treatment with FOLFIRI‐aflibercept are associated with lower PFS.15 Our study shows a strong correlation between the development of hypertension and treatment efficacy, with a 2.7‐fold reduction in the risk of progression.